Public preview. Funding rounds, founders, and growth signals require a free account.

OMass Therapeutics

Biotechnology company discovering small molecule medicines against membrane proteins and intracellular complexes for immunological and orphan diseases.

Series BBiotechOxford, United Kingdom

Last round

Series B

Jan 2023

Stage

Series B

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Sign up to see founders

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Create free account

Growth signals

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Sign up to see signals

Free account unlocks 5 full profiles per day. Pro removes the limit.

Create free account

Track OMass Therapeutics on FlareSight

Get notified the moment OMass Therapeutics files a new round, hires execs, or shows traction signals.

Create free account

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.